These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2609523)
1. [The selective toxicity of 5-hydroxymethyldeoxyuridine for the cells of human adenocarcinoma of the large intestine]. Lockshin A; Meshcherikova VV Vopr Onkol; 1989; 35(11):1327-32. PubMed ID: 2609523 [TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells. Lockshin A; Giovanella BC; Mendoza JT; Warneke C; Stehlin JS Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture. Fernandez-Pol JA; Klos DJ; Hamilton PD Anticancer Res; 1993; 13(1):57-64. PubMed ID: 8476229 [TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of choline kinase inhibitors: a novel target for anticancer drug discovery. Hernández-Alcoceba R; Fernández F; Lacal JC Cancer Res; 1999 Jul; 59(13):3112-8. PubMed ID: 10397253 [TBL] [Abstract][Full Text] [Related]
5. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro. Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127 [TBL] [Abstract][Full Text] [Related]
6. Influence of 1 and 25 Hz, 1.5 mT magnetic fields on antitumor drug potency in a human adenocarcinoma cell line. Ruiz-Gómez MJ; de la Peña L; Prieto-Barcia MI; Pastor JM; Gil L; Martínez-Morillo M Bioelectromagnetics; 2002 Dec; 23(8):578-85. PubMed ID: 12395412 [TBL] [Abstract][Full Text] [Related]
8. Susceptibility of human colon carcinoma cells to anticancer drugs is enhanced by L-histidinol. Warrington RC; Cheng I; Fang WD Anticancer Res; 1994; 14(2A):367-72. PubMed ID: 8017835 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044 [TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and radiotherapy: sequence-dependent efficacy--a preclinical model. Niero A; Emiliani E; Monti G; Pironi F; Turci L; Valenti AM; Marangolo M Clin Cancer Res; 1999 Aug; 5(8):2213-22. PubMed ID: 10473108 [TBL] [Abstract][Full Text] [Related]
11. The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell lines. Burnham BS; Chen SY; Sood A; Spielvogel BF; Miller MC; Hall IH Anticancer Res; 1995; 15(3):951-8. PubMed ID: 7645985 [TBL] [Abstract][Full Text] [Related]
12. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
13. Hybrid aza-steroid alkylators in the treatment of colon cancer. Trafalis DT Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564 [TBL] [Abstract][Full Text] [Related]
14. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Winski SL; Hargreaves RH; Butler J; Ross D Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924 [TBL] [Abstract][Full Text] [Related]
15. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. Sun X; Wong JR; Song K; Hu J; Garlid KD; Chen LB Cancer Res; 1994 Mar; 54(6):1465-71. PubMed ID: 8137249 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel and N-methylformamide: in vitro interactions in human colon cancer cell line. Valenti AM; Niero A; Monti G; Marangolo F; Marangolo M Anticancer Res; 1997; 17(4A):2491-7. PubMed ID: 9252669 [TBL] [Abstract][Full Text] [Related]
17. Highly selective drug combinations for human colon cancer cells resistant in vitro to 5-fluoro-2'-deoxyuridine. Sobrero AF; Handschumacher RE; Bertino JR Cancer Res; 1985 Jul; 45(7):3161-3. PubMed ID: 3159475 [TBL] [Abstract][Full Text] [Related]
18. Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. Bergnes G; Yuan W; Khandekar VS; O'Keefe MM; Martin KJ; Teicher BA; Kaddurah-Daouk R Oncol Res; 1996; 8(3):121-30. PubMed ID: 8823808 [TBL] [Abstract][Full Text] [Related]
19. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells. Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756 [TBL] [Abstract][Full Text] [Related]
20. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]